Revealed on January 6, 2026, by Le Dauphiné libéré, the euthanasia process in Belgium of actor Arnaud Denis, 42 years old, brings to the forefront a chronic post-surgical pain he attributes to a hernia prosthesis placed in Paris in 2023. After the removal of the implant in the United States in April 2024, he says he was only partially relieved. His struggle questions consent and health monitoring.
When the Stage Goes Dark
Arnaud Denis belongs to that family of theater artisans who live in the phrase. In 2003, he founded the Compagnons de la Chimère and rooted himself in a repertoire where the classics serve as seismographs. His recent adaptation of Les Liaisons dangereuses, presented at the Comédie des Champs-Élysées, met with public and critical success. However, a portrait published in Le Monde in 2025 shows him unable to perform, forced to stay offstage for health reasons, while continuing to direct.
Since the 2023 operation, he says, daily life has shrunk. He describes a progressive deterioration, overwhelming fatigue, symptoms that isolate him. "I have no life left," he confides to Dauphiné libéré. The artist’s voice, usually turned towards nuance, hardens into a statement. This leaves no room for metaphors.
Inguinal Hernia Prosthesis: Complications and Unknown Risk
Inguinal hernia is one of the most common surgeries. For years, the placement of a synthetic mesh has become standard. It is supposed to reinforce the wall and limit recurrences. This routine does not prevent complications. Arnaud Denis marks a turning point in October 2023, when his symptoms worsen to the point, according to his account, of hospitalization.
He suggests the hypothesis of an intolerance to the polypropylene hernia mesh, widely used. He does not present it as proof, but as the most coherent explanation in his eyes. Indeed, it links the implant and the pain. There lies a sensitive point. Chronic pain cannot be photographed. It is told. And it sometimes places doctors and patients in a face-off where certainty is lacking for everyone.
In April 2024, he went to the United States for a hernia prosthesis removal, in specialized surgery. He mentions a cost of 40,000 to 50,000 euros. The removal, he says, did not erase the problem. He speaks of partial improvement and a body that continues to alert. Indeed, it is as if the initial gesture left a lasting imprint.
Testimonies and Cold Statistics: ANSM’s Material Vigilance
To break the isolation, Arnaud Denis opens a page on social networks and collects stories. He claims to have gathered about 200 testimonies. They do not constitute a study, but they draw an emotional map. This represents pain spreading through words and eventually demanding a place in the public space. It also reveals the other side of devices: the energy required to be heard when there is no visible wound to show.
The ANSM, on its side, speaks the language of material vigilance. The agency indicates observing an increase in reports since 2023, while reminding that these reports remain low. Indeed, this is low compared to the number of implants placed each year, around 200,000. Between 2020 and 2024, fewer than thirty annual reports have been recorded. This is based on data taken up by the agency and the specialized press, with the hypothesis of under-reporting.
This wide gap fuels misunderstanding. Patients see lives amputated. Institutions see proportions. Yet, both realities can coexist. A rare complication is not fiction. A high frequency is not an argument against the pain of those falling on the wrong side of the curve. Indeed, this does not diminish the suffering of the affected individuals.
Surgeons Qualify, Science Must Decide
Learned societies, including the French Society of Digestive Surgery, remind us of an important fact. Persistent pain after hernia repair is known. Moreover, its causes are multiple and the implant is not the only suspect. Nerve damage, local inflammation, scarring, fixation method, individual vulnerabilities: so many possible paths to lasting pain. Medical publications mention chronic pain that can affect a significant portion of patients. However, the forms that are durably disabling remain a minority.
To move beyond the duel between testimony and isolated figures, an Epi-Phare study is announced, to exploit national health data and better describe postoperative trajectories. The ANSM also says it has strengthened the monitoring of the parietal reinforcement implant market and organized in June 2025 a consultation with patient representatives and professionals to identify avenues, particularly on information and follow-up.
Medtronic, Hernia Prosthesis and the Blind Spot of Consent
The manufacturer Medtronic claims that the implant in question is compliant and that the benefit-risk ratio is positive. This position reminds us that, for the vast majority, these meshes prevent recurrences and allow for quick recovery. But the Denis case highlights another issue, more discreet and sometimes more explosive: that of information before the procedure. Stating a risk also means expressing its rarity without erasing it. It is necessary to describe what happens if the risk occurs, including the potential difficulty of removing an implant.
Arnaud Denis says he did not measure the risk of lasting pain, nor the rarity of specialized teams. He claims to have filed a complaint against X for involuntary injuries and to support a collective action. In these cases, justice seeks causalities. Pain is experienced without definitive proof and over time. This implies renunciations and dependencies.
Belgium, Legal Threshold and Intimate Vertigo
The move towards Belgium reconfigures everything. There, the law has regulated euthanasia since 2002. It requires a medical situation with no way out, linked to a serious and incurable condition. Moreover, it necessitates constant, unbearable, and unrelievable suffering. Furthermore, a voluntary, considered, and repeated request is required. Finally, this strict procedure is conducted by doctors.
In France, the debate on end-of-life has intensified. On May 27, 2025, the National Assembly adopted a bill in the first reading. This concerns the right to assisted dying and is still in the parliamentary process. The case of Arnaud Denis, at the beginning of 2026, arrives as a question posed without precaution: what do we do with chronic suffering when it becomes, for the one who bears it, a condemnation.
The story compels us to hold several truths together. Medical devices have improved countless lives. They can also, rarely, undo them. And it reminds us that, when uncertainty dominates, the essential often comes down to a simple thing: a readable follow-up, clear words, and the certainty, for the patient, of not being left alone in the face of pain. Authorities must measure, monitor, and correct. Doctors must inform, follow up, and recognize pain when it sets in. And society, finally, must look without slogans at what is at stake, between dignity, trust, and consent.